• Synexus further strengthens its presence in Poland with the acquisition of Osteomed
  • Dr Ian Smith founder and global medical director of Synexus awarded an MBE in the Queen’s New Years honours list
  • Top KOLs head Synexus therapeutic advisory boards
  • Synexus’ Pretoria clinical research site delivers world beating performance for Janssen Pharmaceuticals
  • Alan Pilgrim is appointed Chairman of Synexus
  • Synexus forges ahead with record new business signings, expanded therapeutic offerings and a strengthened board

Who we are

Synexus, headquartered in Manchester, continues to pioneer important developments in the clinical trials industry. Through a global network of 26 Dedicated Research Centres (DRCs) in nine countries Synexus provides first class clinical trials data to its clients from pharma, biotechs and CROs.

More about Synexus

What We Do

Synexus recruits patients and runs clinical trials at its own Dedicated Research Centres staffed by full time GCP investigators who work solely on clinical trials. The Synexus model has been designed to:

  • Speed up clinical trials
  • Reduce costs
  • Provide access to millions of patients worldwide

Who We Work For

You will need to download the flash player to view this content.

Synexus’ client base comprises some of the world's leading pharma, biotechs and CROs.   

More about our clients

Our Expertise

Synexus' expertise across a growing number of therapy areas is ensuring clients reach the agreed number of patients, on time and at a competitive cost. 

More about therapy areas

Latest News

Follow Synexus on Twitter

Synexus Newsletter

Synexus Videos

View all videos

Synexus Limited, Registered in England and Wales, Registered number 3724238, Registered Office: Sandringham House, Ackhurst Park, Chorley , Lancashire, PR7 1NY